HUTCHMED

formerly HUTCHMED (China) Limited

Hong Kong, Hong Kong · Founded 2000 · $100.0M raised

Headquarters
Hong Kong
Employees
1001–5000
Founded
2000
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Private EquityJan 2013
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its in-house discovery engine has created more than 20 novel drug candidates, and it runs around 40 clinical trials worldwide, including 13+ registration studies. Its first four medicines are marketed in China, the first of which is also approved in the US, Europe and Japan, supported by a profitable commercial platform with deep pan-China market access.

Summary

HUTCHMED is a Biotech company based in Hong Kong, Hong Kong, founded in 2000. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Jan 2013. Investors include Baring Private Equity, Canada Pension Plan Investment Board and The Carlyle Group.

Funding & Exit History

Secondary MarketSecondary MarketOct 2021

Sign up to see all 4 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HUTCHMED on Indexed.vc
<a href="https://indexed.vc/companies/hutchmed"><img src="https://indexed.vc/api/badge/company/hutchmed" alt="HUTCHMED on Indexed.vc" width="260" height="76" /></a>